What do systematic reviews say?

Clinprost vs lipo‐PGE1

The review found no eligible studies for this question.

• Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Prostanoids vs pentoxifylline

The review found no eligible studies for this question.

• Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Naftopidil vs propiverine (anticholinergic)

• Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 37 participants
  Low

Naftopidil vs Eviprostat (phytotherapy)

• Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 49 participants
  Moderate

Naftopidil vs tamsulosin

• Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  11 studies · 878 participants
  Low

Naftopidil vs silodosin (alpha‐blocker)

• Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 652 participants
  Low

Anti‐EGFR antibody plus chemotherapy vs chemotherapy alone

The review found no eligible studies for this question.

• Epidermal growth factor receptor blockers for the treatment of ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

EGFR tyrosine kinase inhibitor (TKI) vs observation

• Epidermal growth factor receptor blockers for the treatment of ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 835 participants
  Very low

Information provision vs (Optimised) usual care

• Information provision for people with multiple sclerosis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 671 participants
  Low

Probiotics vs placebo

• Probiotics for the prevention or treatment of chemotherapy‐ or radiotherapy‐related diarrhoea in people with cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 72 participants
  Low

Breast surgery plus systemic treatment vs systemic treatment

The review found no eligible studies for this question.

• Breast surgery for metastatic breast cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Botulinum toxin vs observation

The review found no eligible studies for this question.

• Interventions for eye movement disorders due to acquired brain injury 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Edaravone plus corticosteroids vs corticosteroids

The review found no eligible studies for this question.

• Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: bevacizumab vs placebo

The review found no eligible studies for this question.

• Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surgical portosystemic shunts vs devascularisation with splenectomy

• Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 154 participants
  GRADE not reported

B vitamins vs placebo

• Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 138 participants
  Moderate

ATRA in addition to chemotherapy vs chemotherapy alone

The review found no eligible studies for this question.

• Effects of all‐trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML)… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

De‐escalation vs usual care

The review found no eligible studies for this question.

• De‐escalation techniques for managing non‐psychosis induced aggression in adults 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Gene therapy vs no gene therapy control

• Gene therapy for peripheral arterial disease 2018 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 699 participants
  Very low

Delayed chemotherapy vs immediate chemotherapy

• Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 161 participants
  Very low